Legend:
CC = Vancouver Convention Centre
F = Fairmont Waterfront Vancouver
* = applied session ! = JSM meeting theme
307 !
Tue, 7/31/2018,
8:30 AM -
10:20 AM
CC-West 221
Clinical Trial Design-3 — Contributed Papers
Biopharmaceutical Section
Chair(s): Josephine Asafu-Adjei
8:35 AM
Social Media and Clinical Research
Darcy Hille, Merck & Company Inc ; T. Ceesay, Merck
8:50 AM
Incorporating Historical Information into the Analysis of Clinical Trials- a Case Study
Guochen Song, Biogen ; Yiqing Tian, Q2 Sulotions; John Zhong, Biogen; Stacy Lindborg, Biogen Idec
9:05 AM
Systematic Review of Test/Estimation Approach in Comparative Cancer Clinical Studies with Time-To-Event Outcomes
Miki Horiguchi, Kitasato University ; Hajime Uno, Dana Farber Cancer Institute
9:20 AM
Design Considerations in Clinical Trials with Cure Rate Survival Data: a Case Study in Oncology
Grace Liu, Johnson & Johnson ; Steven Sun, J&J; Tzu-min Yhe, janssen pharmaceuticals; Tianmeng Lyu, University of Minnesota; Rao Sudhakar, janssen pharmaceuticals; Bruce Xue, Johnson & Johnson China
9:35 AM
Multiplicity Adjustment for Multiple Endpoints Testing in Overall and Subgroup Populations
Libo Sun, Janssen Pharmaceutical R&D ; Grace Liu, Johnson & Johnson; Rui Qin, Janssen Pharmaceutical R&D
9:50 AM
Statistical Leadership in Clinical Trials: Opportunities from the Draft Estimand Guidance
Jonathan Siegel, Bayer HealthCare Pharmaceuticals Inc.
10:05 AM
Safety Analysis of Clinical Trials in NDA Submissions
Linyun Zhou, Takeda Global Research & Development
